| The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort M Rudwaleit, H Haibel, X Baraliakos, J Listing, E Märker‐Hermann, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 947 | 2009 |
| Successful treatment of active ankylosing spondylitis with the anti–tumor necrosis factor α monoclonal antibody infliximab J Brandt, H Haibel, D Cornely, W Golder, J Gonzalez, J Reddig, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2000 | 695 | 2000 |
| Six‐month results of a double‐blind, placebo‐controlled trial of etanercept treatment in patients with active ankylosing spondylitis J Brandt, A Khariouzov, J Listing, H Haibel, H Sörensen, L Grassnickel, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2003 | 601 | 2003 |
| Baseline radiographic damage, elevated acute‐phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis D Poddubnyy, H Haibel, J Listing, E Märker‐Hermann, H Zeidler, J Braun, ... Arthritis & Rheumatism 64 (5), 1388-1398, 2012 | 566 | 2012 |
| Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis D Poddubnyy, M Rudwaleit, H Haibel, J Listing, E Märker-Hermann, ... Annals of the rheumatic diseases 70 (8), 1369-1374, 2011 | 487 | 2011 |
| Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception … D Poddubnyy, M Rudwaleit, H Haibel, J Listing, E Märker-Hermann, ... Annals of the rheumatic diseases 71 (10), 1616-1622, 2012 | 443 | 2012 |
| Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: results of a twelve‐week randomized, double‐blind, placebo … H Haibel, M Rudwaleit, J Listing, F Heldmann, RL Wong, H Kupper, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2008 | 407 | 2008 |
| Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis H Appel, G Ruiz‐Heiland, J Listing, J Zwerina, M Herrmann, R Mueller, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 389 | 2009 |
| Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis X Baraliakos, H Haibel, J Listing, J Sieper, J Braun Annals of the rheumatic diseases 73 (4), 710-715, 2014 | 335 | 2014 |
| Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised … IH Song, KG Hermann, H Haibel, CE Althoff, J Listing, GR Burmester, ... Annals of the rheumatic diseases 70 (4), 590-596, 2011 | 329 | 2011 |
| Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes X Baraliakos, J Listing, M Rudwaleit, H Haibel, J Brandt, J Sieper, J Braun Annals of the rheumatic diseases 66 (7), 910-915, 2007 | 319 | 2007 |
| Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS) D Poddubnyy, KGA Hermann, J Callhoff, J Listing, J Sieper Annals of the rheumatic diseases 73 (5), 817-823, 2014 | 301 | 2014 |
| Open label trial of anakinra in active ankylosing spondylitis over 24 weeks H Haibel, M Rudwaleit, J Listing, J Sieper Annals of the rheumatic diseases 64 (2), 296-298, 2005 | 271 | 2005 |
| High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis GR Heiland, H Appel, D Poddubnyy, J Zwerina, A Hueber, H Haibel, ... Annals of the rheumatic diseases 71 (4), 572-574, 2012 | 264 | 2012 |
| No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial H Haibel, HC Brandt, IH Song, A Brandt, J Listing, M Rudwaleit, J Sieper Annals of the rheumatic diseases 66 (3), 419-421, 2007 | 249 | 2007 |
| Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-α antibody infliximab X Baraliakos, J Listing, J Brandt, H Haibel, M Rudwaleit, J Sieper, J Braun Rheumatology 46 (9), 1450-1453, 2007 | 240 | 2007 |
| Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti–tumor necrosis factor α … J Braun, X Baraliakos, J Listing, J Davis, D Van Der Heijde, H Haibel, ... Arthritis Care & Research 57 (4), 639-647, 2007 | 231 | 2007 |
| Successful short term treatment of severe undifferentiated spondyloarthropathy with the anti-tumor necrosis factor-alpha monoclonal antibody infliximab. J Brandt, H Haibel, J Reddig, J Sieper, J Braun The Journal of rheumatology 29 (1), 118-122, 2002 | 222 | 2002 |
| Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot study IH Song, F Heldmann, M Rudwaleit, H Haibel, A Weiss, J Braun, J Sieper Annals of the rheumatic diseases 70 (6), 1108-1110, 2011 | 221 | 2011 |
| Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis J Brandt, J Listing, H Haibel, H Sorensen, A Schwebig, M Rudwaleit, ... Rheumatology 44 (3), 342-348, 2005 | 221 | 2005 |
